42 related articles for article (PubMed ID: 9869460)
1. Patient Factors Influencing Intraocular Penetration of Brimonidine-Related Eye Drops in Adults: A Post Hoc Pooled Analysis.
Kunikane E; Orii Y; Inoue A; Inatani M
Ophthalmol Ther; 2023 Dec; 12(6):3083-3098. PubMed ID: 37676633
[TBL] [Abstract][Full Text] [Related]
2. Impact of pH modification of the empirically used tobramycin ophthalmic solution on MIC90 concentration in tears and aqueous humor of donkeys (Equus asinus).
Ibrahim A; Abd-Elrasoul MAA; Sabra MS
BMC Vet Res; 2024 May; 20(1):218. PubMed ID: 38778405
[TBL] [Abstract][Full Text] [Related]
3. Lens concentration of ofloxacin and lomefloxacin in an experimental endophthalmitis model.
Yağci R; Oflu Y; Yağci S; Dinçel A; Kaya E; Duman S; Bozkurt A
Curr Ther Res Clin Exp; 2007 May; 68(3):184-90. PubMed ID: 24683209
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits.
Roy Chowdhury U; Kudgus RA; Rinkoski TA; Holman BH; Bahler CK; Hann CR; Reid JM; Dosa PI; Fautsch MP
PLoS One; 2020; 15(4):e0231841. PubMed ID: 32298376
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic Administration.
Sakai T; Shinno K; Kurata M; Kawamura A
Ophthalmol Ther; 2019 Dec; 8(4):511-517. PubMed ID: 31372937
[TBL] [Abstract][Full Text] [Related]
6. Isolation of three different sizes of exosomes in an Asian population with different retinal diseases before and after treatment: preliminary results.
Wu SY; Hung YC; Chou CC; Chen C; Cheng CM; Chen C; Liou JC; Hsu MY
Bioengineered; 2024 Dec; 15(1):2297320. PubMed ID: 38155415
[TBL] [Abstract][Full Text] [Related]
7. Ascorbic acid export from human donor lenses: is the lens a source of ascorbic acid in the ocular humors?
Li B; Jiang L; Siemerink MJ; Van Severen V; Cunningham WJ; Donaldson PJ; Lim JC
Exp Eye Res; 2024 Jun; ():109972. PubMed ID: 38871164
[TBL] [Abstract][Full Text] [Related]
8. The consistency of Anti-Toxocara IgG between the Aqueous Humor and Vitreous of Patients with Clinically Suspected Ocular Toxocariasis.
Xu Q; Gong C; Yang X; Li J; Zhang Z; Sheng A; Zhang Y; Feng R; Liu Y; Qiao L; Li Y; Li S
Am J Ophthalmol; 2024 Jun; ():. PubMed ID: 38871266
[TBL] [Abstract][Full Text] [Related]
9. MEASUREMENT OF THE HYDRAULIC CONDUCTIVITY OF THE VITREOUS HUMOR.
Penkova AN; Zhang S; Humayun MS; Fraser S; Moats R; Singh Sadhal S
J Porous Media; 2020; 23(2):195-206. PubMed ID: 32494116
[TBL] [Abstract][Full Text] [Related]
10. A novel biomarker assay qualification strategy for rare human matrices - a case study of biomarkers in aqueous humor.
Getz JA; Nguy T; Dere R; Maia M
Bioanalysis; 2024 Mar; ():. PubMed ID: 38506259
[No Abstract] [Full Text] [Related]
11. Topical antibiotic prophylaxis before intravitreal injections: a pilot study.
Trovato Battagliola E; Riveros Cabral RJ; Manco G; Puggioni G; Brancato C; Mangiantini P; Testa F; Malvasi M; Raponi G; Turchetti P; Pacella F; Pacella E
Graefes Arch Clin Exp Ophthalmol; 2023 Oct; 261(10):2953-2959. PubMed ID: 37199800
[TBL] [Abstract][Full Text] [Related]
12. Aqueous Humour Ofloxacin Concentration after Topical Instillation in Patients with Dry Eye Disease.
Kagkelaris K; El Mubarak MA; Plotas P; Panaretos D; Panayiotakopoulos GD; Sivolapenko GB; Georgakopoulos CD
Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013498
[TBL] [Abstract][Full Text] [Related]
13. Penetration of topically applied levofloxacin 0.5% and ofloxacin 0.3% into the vitreous of the non-inflamed human eye.
Puustjärvi T; Teräsvirta M; Nurmenniemi P; Lokkila J; Uusitalo H
Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1633-7. PubMed ID: 16715252
[TBL] [Abstract][Full Text] [Related]
14. Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration.
Hariprasad SM; Mieler WE; Shah GK; Blinder KJ; Apte RS; Holekamp NM; Thomas MA; Chi J; Prince RA
Trans Am Ophthalmol Soc; 2004; 102():149-55; discussion 155-7. PubMed ID: 15747753
[TBL] [Abstract][Full Text] [Related]
15. Subretinal fluid levels of topical, oral, and combined administered ciprofloxacin in humans.
Cekiç O; Batman C; Yaşar U; Başci NE; Zilelioğlu O; Bozkurt A
Br J Ophthalmol; 2000 Sep; 84(9):1061-3. PubMed ID: 10966968
[TBL] [Abstract][Full Text] [Related]
16. Penetration of topical, oral, and combined administered ofloxacin into the subretinal fluid.
Cekiç O; Batman C; Yasar U; Totan Y; Basci NE; Bozkurt A; Zilelioglu O; Kayaalp SO
Br J Ophthalmol; 1999 Oct; 83(10):1183-5. PubMed ID: 10502583
[TBL] [Abstract][Full Text] [Related]
17. Penetration of ofloxacin in human aqueous and vitreous humors following oral and topical administration.
Cekic O; Batman C; Yasar U; Basci NE; Bozkurt A; Kayaalp SO
Retina; 1998; 18(6):521-5. PubMed ID: 9869460
[TBL] [Abstract][Full Text] [Related]
18. Intracorneal, aqueous humor, and vitreous humor penetration of topical and oral ofloxacin.
Donnenfeld ED; Perry HD; Snyder RW; Moadel R; Elsky M; Jones H
Arch Ophthalmol; 1997 Feb; 115(2):173-6. PubMed ID: 9046250
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
